Alyeska Investment Group
SPRB

Alyeska Investment Group’s Spruce Biosciences SPRB Stock Holding History

Alyeska Investment Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41M Buy
81,671
+30,000
+58% +$1.68M 0.01% 513
2026
Q1 		$3.38M Hold
51,671
– – 0.01% 517
2025
Q4 		$4.5M Buy
+51,671
New +$5.54M 0.01% 470
2024
Q1 		– Sell
-5,333
Closed -$1.17M – 640
2023
Q4 		$1.17M Sell
5,333
-8,000
-60% -$924K 0.01% 402
2023
Q3 		$2.26M Hold
13,333
– – 0.02% 383
2023
Q2 		$2.15M Hold
13,333
– – 0.02% 405
2023
Q1 		$2.21M Buy
+13,333
New +$2.48M 0.02% 349
2021
Q3 		– Sell
-259
Closed -$218K – 816
2021
Q2 		$218K Buy
+259
New +$276K ﹤0.01% 683

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Alyeska Investment Group's SPRB Position: Q2 2026 in Review

Alyeska Investment Group increased its Spruce Biosciences (SPRB) stake by 58% in Q2 2026, buying an estimated $1.68M and bringing the position to 81,671 shares worth $4.41M. The position accounts for 0.01% of the portfolio, ranked #513.

Alyeska Investment Group first reported a position in SPRB in Q2 2021 and has held it in 8 quarters since. The position peaked at $4.5M in Q4 2025. 64 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Alyeska Investment Group held 81,671 shares of Spruce Biosciences worth $4.41M as of Q2 2026.
  • Alyeska Investment Group bought 30,000 Spruce Biosciences shares in Q2 2026, an estimated $1.68M.
  • Spruce Biosciences made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #513 holding.
  • Alyeska Investment Group first reported a position in Spruce Biosciences in Q2 2021 and has held it in 8 quarters since.
  • Alyeska Investment Group's Spruce Biosciences position peaked at $4.5M in Q4 2025.
  • 64 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.